Omnicell Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for cli...
Latest News
3 days ago · seekingalpha.com
Omnicell, Inc. (OMCL) Q3 2026 Earnings Call TranscriptOmnicell, Inc. ( OMCL ) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDT Company Participants David Unger - Vice President of Investor Relations Randall Lipps - Founder, Executive Chairman & CEO Nnamdi Njoku - President & COO Baird Radford Conference Call Participants Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division Jessica Tassan - Piper Sandler & Co., Research Division Allen Lutz - BofA Securities, Research Division David Larsen - BTIG, LLC, Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division Gene Mannheimer William Sutherland - StoneX Financial, Inc., Research Division Presentation Operator Hello, everyone. Thank you for joining us, and welcome to the Omnicell Third Quarter 2026 Financial Results Call.
3 days ago · marketbeat.com
Omnicell Q3 Earnings Call HighlightsOmnicell NASDAQ: OMCL reported third-quarter 2026 revenue and non-GAAP EBITDA above the high end of its prior guidance, while executives said the company is preparing to begin shipments of its Titan XT automated dispensing hardware and remains on track for first-half 2027 general availability of its OmniSphere cloud platform.
4 days ago · zacks.com
Here's What Key Metrics Tell Us About Omnicell (OMCL) Q3 EarningsWhile the top- and bottom-line numbers for Omnicell (OMCL) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
4 days ago · zacks.com
Omnicell (OMCL) Q3 Earnings and Revenues Top EstimatesOmnicell (OMCL) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.51 per share a year ago.
20 days ago · zacks.com
Is This the Right Time to Retain Omnicell Stock in Your Portfolio?OMCL raises its 2026 earnings outlook on cost discipline and efficiency, but rising memory costs and delayed Titan XT adoption pose challenges.
25 days ago · businesswire.com
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026.
1 month ago · zacks.com
Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2 months ago · zacks.com
Here's Why Omnicell (OMCL) is a Strong Value StockWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2 months ago · prnewswire.com
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy OperationsIntegration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance processes. BOSTON, Sept.
2 months ago · businesswire.com
Omnicell to Present at the Wells Fargo 21st Annual Healthcare ConferenceFORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove OMCL